These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 27688247

  • 1. Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer's disease.
    Scarr E, McLean C, Dean B.
    J Neural Transm (Vienna); 2017 Mar; 124(3):273-284. PubMed ID: 27688247
    [Abstract] [Full Text] [Related]

  • 2. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.
    Piggott MA, Owens J, O'Brien J, Colloby S, Fenwick J, Wyper D, Jaros E, Johnson M, Perry RH, Perry EK.
    J Chem Neuroanat; 2003 Mar; 25(3):161-73. PubMed ID: 12706204
    [Abstract] [Full Text] [Related]

  • 3. Muscarinic receptor binding changes in postmortem Parkinson's disease.
    McOmish C, Pavey G, McLean C, Horne M, Dean B, Scarr E.
    J Neural Transm (Vienna); 2017 Feb; 124(2):227-236. PubMed ID: 27873015
    [Abstract] [Full Text] [Related]

  • 4. The use of a modified [3H]4-DAMP radioligand binding assay with increased selectivity for muscarinic M3 receptor shows that cortical CHRM3 levels are not altered in mood disorders.
    Jeon WJ, Gibbons AS, Dean B.
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec 02; 47():7-12. PubMed ID: 23962466
    [Abstract] [Full Text] [Related]

  • 5. Changes in cholinergic and glutamatergic markers in the striatum from a sub-set of subjects with schizophrenia.
    Dean B, Thomas N, Lai CY, Chen WJ, Scarr E.
    Schizophr Res; 2015 Dec 02; 169(1-3):83-88. PubMed ID: 26545297
    [Abstract] [Full Text] [Related]

  • 6. Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies.
    Teaktong T, Piggott MA, Mckeith IG, Perry RH, Ballard CG, Perry EK.
    Behav Brain Res; 2005 Jun 20; 161(2):299-305. PubMed ID: 15922057
    [Abstract] [Full Text] [Related]

  • 7. Loss of muscarinic M4 receptors in hippocampus of Alzheimer patients.
    Mulugeta E, Karlsson E, Islam A, Kalaria R, Mangat H, Winblad B, Adem A.
    Brain Res; 2003 Jan 17; 960(1-2):259-62. PubMed ID: 12505680
    [Abstract] [Full Text] [Related]

  • 8. Altered hippocampal muscarinic M4, but not M1, receptor expression from subjects with schizophrenia.
    Scarr E, Sundram S, Keriakous D, Dean B.
    Biol Psychiatry; 2007 May 15; 61(10):1161-70. PubMed ID: 17239354
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Loss of [3H]4-DAMP binding to muscarinic receptors in the orbitofrontal cortex of Alzheimer's disease patients with psychosis.
    Tsang SW, Francis PT, Esiri MM, Wong PT, Chen CP, Lai MK.
    Psychopharmacology (Berl); 2008 Jun 15; 198(2):251-9. PubMed ID: 18373228
    [Abstract] [Full Text] [Related]

  • 11. Levels of [(3)H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1.
    Dean B, Soulby A, Evin GM, Scarr E.
    Schizophr Res; 2008 Dec 15; 106(2-3):229-36. PubMed ID: 18790604
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Heterogeneous binding of [3H]4-DAMP to muscarinic cholinergic sites in the rat brain: evidence from membrane binding and autoradiographic studies.
    Araujo DM, Lapchak PA, Quirion R.
    Synapse; 1991 Nov 15; 9(3):165-76. PubMed ID: 1776129
    [Abstract] [Full Text] [Related]

  • 14. Muscarinic receptor subtypes in human nasal mucosa: characterization, autoradiographic localization, and function in vitro.
    Okayama M, Mullol J, Baraniuk JN, Hausfeld JN, Feldman B, Merida M, Shelhamer JH, Kaliner MA.
    Am J Respir Cell Mol Biol; 1993 Feb 15; 8(2):176-87. PubMed ID: 8427708
    [Abstract] [Full Text] [Related]

  • 15. Distribution of m1 muscarinic acetylcholine receptors in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies-an immunohistochemical study.
    Shiozaki K, Iseki E, Hino H, Kosaka K.
    J Neurol Sci; 2001 Dec 15; 193(1):23-8. PubMed ID: 11718746
    [Abstract] [Full Text] [Related]

  • 16. Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation.
    Crook JM, Tomaskovic-Crook E, Copolov DL, Dean B.
    Biol Psychiatry; 2000 Sep 01; 48(5):381-8. PubMed ID: 10978721
    [Abstract] [Full Text] [Related]

  • 17. Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia.
    Gibbons AS, Scarr E, Boer S, Money T, Jeon WJ, Felder C, Dean B.
    Int J Neuropsychopharmacol; 2013 Feb 01; 16(1):37-46. PubMed ID: 22338582
    [Abstract] [Full Text] [Related]

  • 18. N-methyl-D-aspartate receptor complex in the hippocampus of elderly, normal individuals and those with Alzheimer's disease.
    Ułas J, Brunner LC, Geddes JW, Choe W, Cotman CW.
    Neuroscience; 1992 Jul 01; 49(1):45-61. PubMed ID: 1407551
    [Abstract] [Full Text] [Related]

  • 19. Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia.
    Newell KA, Zavitsanou K, Jew SK, Huang XF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):225-33. PubMed ID: 16901598
    [Abstract] [Full Text] [Related]

  • 20. Differential modification of muscarinic cholinergic receptors in the hippocampus of patients with Alzheimer's disease: an autoradiographic study.
    Probst A, Cortés R, Ulrich J, Palacios JM.
    Brain Res; 1988 May 31; 450(1-2):190-201. PubMed ID: 3401711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.